Cargando…
Serum galectin‐3 as a biomarker for screening, early diagnosis, prognosis and therapeutic effect evaluation of pancreatic cancer
Galectin‐3 plays an important role in cell‐cell adhesion, macrophage activation, angiogenesis, metastasis and apoptosis and is overexpressed in pancreatic cancer. We explored the importance of galectin‐3 in the screening, early diagnosis, prognosis and therapeutic effect evaluation of pancreatic can...
Autores principales: | Yi, Nan, Zhao, Xuying, Ji, Jie, Xu, Minxue, Jiao, Yujie, Qian, Tianyang, Zhu, Shengze, Jiang, Feng, Chen, Jianhua, Xiao, Mingbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576229/ https://www.ncbi.nlm.nih.gov/pubmed/32886424 http://dx.doi.org/10.1111/jcmm.15775 |
Ejemplares similares
-
Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021) -
Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer
por: Han, Su-xia, et al.
Publicado: (2015) -
Serum galectins as potential biomarkers of inflammatory bowel diseases
por: Yu, Tony B., et al.
Publicado: (2020) -
Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021) -
Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels
por: Seifert, Adrian M., et al.
Publicado: (2020)